Emerging Company Profile

Orna: turning circular RNAs into therapies

Emerging Company Profile: Orna launches with $80M to develop circular RNA therapies

Orna, seeded and incubated by MPM, launches with an $80 million series A and a platform of circular RNA therapies packaged in lipid nanoparticles for delivery to desired cells and tissues.

Orna emerged from stealth